Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FY5JZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,547
Award facts
- Contract value 100% obligated
- $15,546.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a $15,546.70 firm fixed-price delivery order by the Defense Logistics Agency on November 24, 2025, for the supply of Wegovy 1.7 mg/0.75 mL pen injections. The contract, which carries an ultimate completion date of November 25, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the supply of a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp leverages its prime indefinite delivery vehicle to fulfill federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio demonstrates its capability to supply specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains through competitively awarded delivery orders utilizing firm fixed pricing. This particular order for Wegovy, a GLP-1 receptor agonist medication used in diabetes and weight management treatment, reflects the company's role in supporting the military health system's pharmaceutical requirements.
Quick answers
Who was awarded contract SPE2DR26FY5JZ?
SPE2DR26FY5JZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FY5JZ worth?
The government has obligated $15,547 on SPE2DR26FY5JZ.
Is contract SPE2DR26FY5JZ an order under another contract?
Yes. SPE2DR26FY5JZ is a delivery order under SPE2DR25D1006, an indefinite delivery contract.
Was contract SPE2DR26FY5JZ competed?
The extent of competition for SPE2DR26FY5JZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award